Gwilym Attwell is a Principal in Fish & Richardson’s Delaware* office, managing the local presence of Fish’s highly regarded patent prosecution and counseling practice. Mr. Attwell’s practice is focused on U.S. and foreign patent prosecution, opinion work, due diligence studies, and client counseling in the fields of biotechnology, medical devices, and pharmaceuticals. He also assists clients in the strategic development and monetization of internal patent portfolios, patent process implementation and the assessment of third-party IP collaborations. In addition, Mr. Attwell works with clients on post-grant proceedings, including inter partes review and post-grant review petitions, and general post-grant patent strategy. He is a frequent lecturer on topics related to practice before the Patent Trial and Appeal Board.
Mr. Attwell has counseled clients ranging from start-ups and emerging companies to Fortune 500 corporations on biotech, chemical, pharmaceutical, and medical device patent applications. His technical experience includes vaccines, antibodies, genomics, polypeptides, small molecule inhibitors, gene therapy, diagnostics, and therapeutics. Mr. Attwell has been recognized by Intellectual Asset Management as “The World’s Leading Patent Practitioners” since 2012, and is described as “a life sciences whiz who is a ‘go to’ adviser on IP development and monetisation for prestigious innovators.” IAM also describes Mr. Attwell as “high skilled, yet very approachable – a great combination – and will answer a question or deal with a problem at a moment’s notice.”
Prior to his legal career, Mr. Attwell’s technical experience includes serving as a pharmacologist at Wyeth-Ayerst Research in the Bone Metabolism and Osteoporosis Research department, where he developed and implemented high-throughput screening assays to identify lead compounds and performed basic research using cell and molecular biology. He was also a research technician at the Cleveland Clinic Research Institute, where he performed research on pathogenic viruses, e.g., vesicular stomatitis virus and human parainfluenza viruses.
*Not admitted to practice in Delaware – practice in Delaware limited to federal courts and agencies listed below or otherwise authorized by law.
June 20, 2019
Fish & Richardson Receives Top “Gold” Ranking from IAM Patent 1000 for National Patent Litigation Practice
May 22, 2019
Fish & Richardson Announces 32 Attorneys Named “IP Stars” by Managing Intellectual Property Magazine
June 2nd, 2019 | 2:00 pm EDT
Consero 2019 Global IP Management Forum
April 2nd, 2019 | 8:45 am EDT
Pittsburgh Venture Capital Association (PVCA) 3 Rivers Venture Fair
December 2nd, 2018 | 1:00 pm PST
Consero: IP Forum for Life Sciences
September 27, 2018
Fish & Richardson Announces 13 Principals Named 2018 “Life Sciences Stars” by LMG Life Sciences
June 14, 2018
Fish Receives Top “Gold” Ranking from IAM Patent 1000 for National Patent Litigation Practice
Fish Litigation Blog
June 13, 2018
Fish Obtains First PGR Reversal at Federal Circuit in Altaire Pharmaceuticals, Inc. v. Paragon Bioteck, Inc.
Authors: Oliver J. Richards, Ahmed J. Davis, Gwilym J. O. Attwell, Craig Countryman
April 19th, 2018 | 5:30 pm EDT
2018 Franklin Institute Awards Ceremony & Dinner
April 24th, 2017
Consero 2017 IP Forum for Life Sciences
February 7th, 2013
Bio NJ 20th Anniversary Annual Dinner Meeting
April 16th, 2014
Delaware Bio 2014 Annual Awards Gala